Catalyst Wire Dossier Catalyst Wire Dossier

Amoxicillin/clavulanic acid chewable tablets 400 mg/57 mg

amoxicillin/clavulanic acid · Ranbaxy Laboratories Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Amoxicillin/clavulanic acid chewable tablets 400 mg/57 mg, covering 2008-10-23 to 2008-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fed Conditions [NA]

See pricing